Stockreport

Roivant Sciences: Cashing In On Vants And Ventures [Seeking Alpha]

Roivant Sciences Ltd.  (ROIV) 
PDF Its pipeline includes promising drugs like IMVT-1402, despite some clinical risks. Financially, Roivant is well-capitalized with $6.67 billion in cash against minimal [Read more]